- MK I first learned about Dr
Full AI Image Prompt: Create a clinical safety infographic titled GHK-Cu Safety Considerations by Route. Use a three-column matrix labeled Topical products, Wound-care study context, and Injectable or compounded preparations. Under topical products, include skin irritation, allergic reaction, and formulation sensitivity. Under wound-care study context, include study exclusions, copper or peptide sensitivity, and dressings or adhesives. Under injectable or compounded preparations, include limited human safety data, peptide-related impurities, aggregation risk, and immunogenicity risk. Use a calm medical style, white background, simple icons, and subtle copper-blue accents
Your provider reviews your health history, current medications, and treatment goals before recommending any specific peptide or combination
no lethal or acutely toxic dose identified across roughly a 3,300x range (6 mcg/kg to 20 mg/kg) Coagulation: rat male aPTT shortened ~10% at 1 and 4 mg/kg, dog male aPTT prolonged ~2025%, both reversible